Cost-Effectiveness Analysis of Salmeterol/Fluticasone Propionate 50/500μg vs Fluticasone Propionate 500μg in Patients with Corticosteroid-Dependent Asthma V: Results

被引：0
作者：
Willem R. Pieters
Bo Lundbäck
Seema Sondhi
Martin J. Price
Robert M.A. Thwaites
机构：
[1] Elkerliek Ziekenhuis,Respiratory Unit
[2] National Institute for Working Life,Global Health Outcomes
[3] Glaxo Wellcome,undefined
来源：
PharmacoEconomics | 1999年 / 16卷
关键词：
Asthma; Adis International Limited; Fluticasone Propionate; Salmeterol; Formoterol;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Methods: An economic analysis was performed to compare the cost effectiveness of a new formulation combining salmeterol 50μg and fluticasone propionate 500μg in a multidose dry powder (Diskus™) inhaler (n = 167) with that of fluticasone propionate (FP) 500μg (n = 165) also delivered via the Diskus™ in patients with corticosteroid-dependent asthma. Clinical data were obtained from a recent European multicentre trial; the economic analysis adopted a Swedish healthcare perspective.
引用
收藏
页码：29 / 34
页数：5
相关论文
共 29 条
[1]  
Greening AP(1994)Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group Lancet 344 219-24
[2]  
Ind PW(1996)Comparison of addition of salmeterol to inhaled steroids with doubling the dose of inhaled steroids Am J Respir Crit Care Med 153 1481-8
[3]  
Northfield M(1997)Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group N Engl J Med 337 1405-11
[4]  
Woolcock A(1998)Inhaled fluticasone propionate and salmeterol in moderate adult asthma. I: Lung function and symptoms Am J Respir Crit Care Med 157 A416-9
[5]  
Lundbäck B(1998)Inhaled fluticasone propionate and salmeterol in moderate adult asthma. II: Exacerbations Am J Respir Crit Care Med 157 A415-6
[6]  
Ringdal N(1999)The addition of salmeterol to fluticasone propionate versus increasing the dose of fluticasone propionate in patients with persistent asthma Ann Allergy Asthma Immunol 82 383-14
[7]  
Pauwels RA(1998)Effectiveness of a new salmeterol/fluticasone propionate (50-500 micrograms) combination inhaler in patients with reversible airways obstruction Eur Respir J 12 35-72
[8]  
Lofdahl CG(1999)Cost-effectiveness analyses of salmeterol/fluticasone propionate combination product and fluticasone propionate in patients with asthma. II: Study methodologies Pharmacoeconomics 16 9-52
[9]  
Postma DS(1995)A comparison of the cost-effectiveness of alternative prophylactic therapies in the treatment of adult asthma Br J Med Econ 8 65-S21
[10]  
Ind PW(1993)The episode-free day as a composite measure of effectiveness. An illustrative economic evaluation of formoterol versus salbutamol in asthma therapy Pharmacoeconomics 4 345-undefined
123